1-9 of 9
Cu Nguyen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia - a COG and Tpaml Study

Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Jason E. Farrar, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, Amanda R. Leonti, MS, Tiffany A. Hylkema, BS, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, Edward Anders Kolb, MD, Cu Nguyen, Daoud Meerzaman, Timothy Junius Triche, Jr., PhD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2741.
https://doi.org/10.1182/blood-2019-127318
Published: 2019
Journal Articles

Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis

Yu Fan, Ying Hu, Cu Nguyen, Chunhua Yan, Rhonda E. Ries, MA, Hamid Bolouri, PhD, Jenny L. Smith, MSc, MD, Qingrong Chen, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD, Daoud Meerzaman
Journal: Blood
Blood (2017) 130 (Supplement 1): 3792.
https://doi.org/10.1182/blood.V130.Suppl_1.3792.3792
Published: 2017
Journal Articles

Comprehensive Clinical Genomic Profiling Defines Age-Associated Molecular Targets in Pediatric and Adult Acute Myeloid Leukemia

Katherine Tarlock, MD, Shan Zong, Ries E Rhonda, Mark Bailey, MSc, Samantha Morley, PhD, Sohail Balasubramanian, M.S., Rachel Erlich, PhD, Doron Lipson, PhD, Geoff Otto, PhD, Jo-Anne Vergillo, MD, Cu Nguyen, Qingron Chen, Daoud Meerzaman, PhD, E. Anders Kolb, MD, Jeff Ross, MD, Tariq I Mughal, MD, Phil Stephens, PhD, Vincent A. Miller, MD, Soheil Meshinchi, MD PhD, Jie He, PhD
Journal: Blood
Blood (2016) 128 (22): 596.
https://doi.org/10.1182/blood.V128.22.596.596
Published: 2016
Journal Articles

PIM3-SCO2 Fusion Is a Novel Transcription-Induced Chimera That Is Highly Prevalent In Childhood AML

Julia Kuhn, BA, Daoud Meerzaman, MD, Rhonda E. Ries, MA, Filippo Milano, MD, PhD, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Jaime Guidry-Auvil, Ph.D., Tanja M. Davidsen, PhD, Malcolm A. Smith, MD, PhD, Yan Chunhua, Chih Hao Hsu, Cu Nguyen, Daniela S. Gerhard, Ph.D., Daniel Wai, Robert J. Arceci, MD, PhD, Soheil Meshinchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2549.
https://doi.org/10.1182/blood.V122.21.2549.2549
Published: 2013
Journal Articles

Overcoming Drug Resistance In Acute Lymphoblastic Leukemia by Inhibition of CBP/γ-Catenin

Enzi Jiang, MD, PhD, Eugene Park, Cu Nguyen, James Yoon, Yao-Te Hsieh, Mignon L. Loh, M.D., Markus Muschen, MD, Michael Kahn, Yong-mi Kim, MD, MPH
Journal: Blood
Blood (2010) 116 (21): 3264.
https://doi.org/10.1182/blood.V116.21.3264.3264
Published: 2010
Journal Articles

The Gamma Catenin/CBP Complex Maintains Survivin Transcription In β-Catenin Deficient/Depleted Cancer Cells.

Yong-Mi Kim, MD, MPH, PhD, Hong Ma, Ph.D., Vivian Oehler, MD, Enzi Jiang, MD, PhD, Cu Nguyen, David P. Masiello, MD, Han Liu, Yi Zhao, MD, PhD, Jerald P. Radich, MD, Michael Kahn
Journal: Blood
Blood (2010) 116 (21): 1218.
https://doi.org/10.1182/blood.V116.21.1218.1218
Published: 2010
Journal Articles

Role of Survivin in Drug Resistant B-Cell Acute Lymphoblastic Leukemia.

Eugene Park, Enzi Jiang, MD, PhD, Gregor von Levetzow, Cihangir Duy, Lars Klemm, Yao-Te Hsieh, Asha Kadavallore, Hong Ma, PhD, Yi Zhao, MD, Cu Nguyen, John Groffen, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD, Michael Kahn, PhD, Yong-Mi Kim, MD
Journal: Blood
Blood (2009) 114 (22): 10.
https://doi.org/10.1182/blood.V114.22.10.10
Published: 2009
Journal Articles

Targeting Survivin Using ICG-001 May Overcome Drug Resistance in Primary B-Cell Acute Lymphoblastic Leukemia.

Enzi Jiang, MD, PhD, Eugene Park, Carlton Scharman, Yao-Te Hsieh, Asha Kadavallore, Cu Nguyen, Yi Zhao, MD, Michael McMillan, PhD, John Groffen, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD, Michael Kahn, PhD, Yong-Mi Kim, MD
Journal: Blood
Blood (2009) 114 (22): 3072.
https://doi.org/10.1182/blood.V114.22.3072.3072
Published: 2009
Journal Articles

Preclinical Evaluation of CBP/β-catenin Inhibition as a New Strategy for Drug Resistant Acute Lymphoblastic Leukemia.

Yong-Mi Kim, MD, MPH, Eugene Park, Colin Lorentzen, Brian De La Torre, Yao-Te Hsieh, Hannah Whang, Lars Klemm, Cu Nguyen, PhD, Michael McMillan, PhD, Jia-Ling Teo, PhD, Markus Muschen, MD, Michael Kahn, PhD
Journal: Blood
Blood (2007) 110 (11): 1596.
https://doi.org/10.1182/blood.V110.11.1596.1596
Published: 2007